Carlos Fernandez-Catalan

Title: The Innovations of Carlos Fernandez-Catalan

Introduction

Carlos Fernandez-Catalan is a notable inventor based in Martinsried-Planegg, Germany. He has made significant contributions to the field of biochemistry, particularly in the study of tumor necrosis factor-alpha converting enzyme (TACE). His work has implications for understanding and treating various diseases.

Latest Patents

Carlos holds a patent for a "Crystalline TNF-α-converting enzyme and uses thereof." This patent describes the production, purification, and crystallization of TACE. The three-dimensional coordinates of the crystal are obtained through X-ray diffraction. These coordinates can be recorded on a computer-readable medium or stored in video memory, facilitating the study of TACE. Additionally, the coordinates are instrumental in designing, screening, and developing compounds that interact with TACE. He has 1 patent to his name.

Career Highlights

Throughout his career, Carlos has worked with prominent organizations, including Immunex Corporation and the Max Planck Institute for Biochemistry. His research has contributed to advancements in biochemistry and therapeutic development.

Collaborations

Carlos has collaborated with esteemed colleagues such as Roy A. Black and Raymond J. Paxton. Their joint efforts have furthered the understanding of TACE and its potential applications.

Conclusion

Carlos Fernandez-Catalan's innovative work in biochemistry, particularly regarding TACE, showcases his contributions to science and medicine. His patent and collaborations highlight the importance of research in developing new therapeutic strategies.